LRRC32 and neoplasm: In the TME, thrombin cleaves glycoprotein A repetitions predominant (GARP) on the platelet surface, liberating surface-bound TGF-ß (161), which activates CAFs to lay down ECM that restricts CD8+ T-cells to the periphery of the tumor (162).